The Takeover Panel granted the extension following a request from Beazley's board. Under UK takeover rules, Zurich had faced a February 16 deadline to either announce a firm intention to make an offer or withdraw from the process.
The agreement in principle announced on February 4 values Beazley at approximately £8 billion. Under the proposed terms, shareholders would receive up to 1,335 pence per share, comprising 1,310 pence in cash plus up to 25 pence in permitted dividends.
The offer represents a 62.8% premium to Beazley's closing price on January 16, and a 34.6% premium to its all-time high of 973 pence recorded on June 6, 2025.
The current agreement follows months of negotiations after Beazley rejected multiple offers. Zurich first approached the specialist insurer in June 2025 with three separate bids, the highest valuing Beazley's equity at £8.4 billion with an offer of 1,315 pence per share.
Beazley's board subsequently rejected additional offers of 1,230 pence on January 4, 2026 and 1,280 pence on 19 January 2026 before reaching the current agreement in principle.
Any firm offer from Zurich remains subject to customary pre-conditions and regulatory requirements under the UK Takeover Code. The deal requires approvals from both the Prudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA).
The PRA handles prudential supervision ensuring financial soundness and market stability, whilst the FCA oversees conduct. On a change of control, the PRA takes the lead but consults with the FCA, the law firm notes.
For groups with cross-border activities, the PRA coordinates with other national and international regulators to ensure effective group-wide supervision. The regulator may require a group to establish an intermediate holding company in the UK for group supervision purposes.
Antitrust scrutiny also looms. Clearey Gottlieb notes that dealmakers should continue to expect rigorous antitrust enforcement, particularly in concentrated industries.
Elevated antitrust reverse termination fees, long outside dates and heavily negotiated regulatory covenants are likely to remain features of the current deal cycle, the firm says.
The extension allows Zurich to complete its confirmatory due diligence on the specialist insurer. The process is progressing as planned with support from Beazley's board and management, according to the announcement.
The proposed transaction would create a speciality insurance platform with approximately US$15 billion in gross written premiums. The combination would leverage Beazley's established presence at Lloyd's of London alongside Zurich's existing speciality operations, which currently maintain a scale of about US$9 billion.
Under Rule 2.6(a) of the Takeover Code, Zurich must now announce a firm intention to make an offer by 5pm London time on 4 March or state it will not proceed. The deadline can be extended further with Takeover Panel consent. The companies noted that no certainty exists that a firm offer will be made.
